Breast Adenocarcinoma clinical trials

Explore recruiting breast adenocarcinoma clinical trials.

Recruiting breast adenocarcinoma studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Breast Adenocarcinoma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A phase II study of Pembrolizumab plus Carboplatin in BRCA-related metastatic breast cancer

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

Breast Adenocarcinoma trials by city

Breast Adenocarcinoma in Toronto Breast Adenocarcinoma in Vancouver Breast Adenocarcinoma in Montreal Breast Adenocarcinoma in Calgary Breast Adenocarcinoma in Edmonton Breast Adenocarcinoma in Ottawa Breast Adenocarcinoma in Winnipeg Breast Adenocarcinoma in Quebec City Breast Adenocarcinoma in Hamilton Breast Adenocarcinoma in Kitchener Breast Adenocarcinoma in London Breast Adenocarcinoma in Halifax Breast Adenocarcinoma in New York Breast Adenocarcinoma in Los Angeles Breast Adenocarcinoma in Chicago Breast Adenocarcinoma in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease